Agencourt Genomic Services Collaborates in New Study on Breast and Colon Cancer Genes
Agencourt Bioscience Corporation, a Beckman Coulter company, has announced that its Genomic services were integral in a breakthrough Johns Hopkins study on the genetic code for breast and colon cancers. A recent report on that study, published this month in Science Express, was co-authored by James Hartigan, an Agencourt project manager. The research identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control. The study provides an understanding into disease processes and is expected to drive cancer research for years to come.
Most of the sequencing work and data generation for the study were done by Agencourt's Genomic Services, which has a long-standing relationship with the Johns Hopkins Kimmel Cancer Center scientists. Agencourt Bioscience, as a collaborator, worked closely with the study leader, Dr. Victor Velculescu.
Other news from the department science
